Normalized Tm Calling for Specific Nucleic Acid Assay Identification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current PCR systems face challenges in distinguishing between closely related pathogens due to broad Tm value ranges, leading to difficulties in accurately identifying target nucleic acid sequences, especially when variations in pouch chemistry, amplicon amounts, and instrument characteristics affect melting temperatures.
Innovation Solution
A method and system for generating an array-specific range of Tm values by using a control sample to calculate a relationship between identified and expected Tm values, allowing for a narrower, normalized range to improve specificity and sensitivity in identifying target nucleic acid sequences.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If raw TM values are used directly for analyte identification, then the process is simple and fast, but identification accuracy is poor due to assay-specific variations and lack of standardization
Solution Approach 1:
The patent transforms raw TM values into normalized TM values by applying assay-specific calibration curves and mathematical transformations. This parameter change standardizes the data across different assays and platforms, enabling accurate analyte identification while maintaining computational efficiency through algorithmic processing rather than complex hardware systems.
Solution Approach 2:
The patent introduces normalized TM values as an intermediary representation between raw assay data and final analyte identification. This intermediary layer standardizes the data format and enables universal comparison across different assays, resolving the contradiction by adding a processing layer that improves accuracy without requiring overly complex systems.
2Measurement precision
If assay-specific calibration curves are applied to each sample, then measurement accuracy is improved, but processing time and computational resources increase
Solution Approach 1:
The patent pre-calculates and stores normalized TM values during the assay development phase, creating lookup tables or reference datasets. During actual sample processing, these pre-computed values are retrieved and applied directly, avoiding time-consuming real-time calculations while maintaining high quantification accuracy across different assays.
Solution Approach 2:
The patent creates standardized copies of calibration curves and reference data that can be rapidly applied to multiple samples. Instead of performing unique calculations for each sample, the system uses replicated reference data structures that enable fast processing while preserving measurement precision through consistent application of standardized transformation parameters.
3Adaptability or versatility
If multiple assays are standardized to a common platform, then interoperability and data comparability improve, but assay design flexibility and optimization are reduced
Solution Approach 1:
The patent segments the standardization process into modular components: assay-specific calibration curves, universal normalization algorithms, and a common data output format. This segmentation allows each assay to be optimized independently for its specific analytical requirements while automatically integrating into the unified platform through standardized processing steps, thus maintaining both flexibility and comparability.
Solution Approach 2:
The patent implements dynamic normalization where the degree of standardization can be adjusted based on the specific assay characteristics and application requirements. The system can operate in fully standardized mode for maximum comparability or in flexible mode allowing assay-specific optimizations, enabling the platform to adapt between these extremes without compromising either cross-assay consistency or individual assay performance.
Data Source
Figure 1
Figure 2
Figure 3
AI summary
Techniques are provided for generating an array-specific range of Tm values to be used for calling a sample in a given array positive or negative for a target nucleic acid sequence. A sample well in an array is provided with a control sample containing a control nucleic acid sequence. The control sample is amplified by thermal cycling the sample well. A Tm value for the control sample is identified and compared to an expected Tm value for the control nucleic acid sequence to calculate a relationship between the identified control Tm value and the expected control Tm value. By applying this relationship to an expected Tm value for a target nucleic acid sequence, an array-specific range of Tm values for the target nucleic acid sequence is generated and can be used for calling an experimental sample in the same array positive or negative for the target nucleic acid sequence.